MCAR Message Board - Msg: 2136858

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : MCAR

MCAR 0.0650

-36.3%

Jan 31 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Andrew Q. Viet who wrote (32)	9/7/1997 11:08:00 PM
From: Bisset	of 467

CAN DICK DAVIS DO IT . . . A G A I N ! ? ! Now the "BIG NEWS!"... MedCare Technologies, Inc. (OTC 8 MCAR) A major player in the Bio-Medical industry who specializes in the treatment of Urinary Incontinence (UI). It's a 16 billion-dollar industry and one where MedCare is virtually alone in the non-drug, non-surgical treatment and cure of UI. If you know someone who was following MedCare last spring, they would remember the breakout it experienced due to the "BUY" recommendation of the Dick Davis Digest. Dick Davis (www.dickdavis.com) is one of America's most influential financial analysts and stock market gurus (the Dick Davis Digest costs $1500 /yr. for a subscription). If you're interested in MCAR - or just a believer that history DOES repeat itself - Dick Davis has just come out with his September-October issue - with an even stronger "BUY" recommendation for MedCare. If last January-February was any indication - MCAR jumped over 88% ($4.375 to $8.25) and maintained it for many months - we should see some significant upward momentum. Check out all their latest info and charts on The Net Investor web site at thenetinvestor.com and call MCAR's investor relations at 1-800-611-3388... Regards, John The Net Investor

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next